Assessment of Advanced Imaging Techniques in the Evaluation and Management of Prostate Cancer
Status: Withdrawn
Intervention Type: Procedure, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
MRI is being increasingly relied upon for detection, staging and management of prostate cancer. In this study patients with risk of prostate cancer will be recommended to have a pelvic MRI prior to the standard biopsy of the prostate and standard treatment of any detected prostate cancer. The results of the MRI will be compared to standard diagnosis techniques to see if cancer can be more accurately detected.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 40
Maximum Age: 90
Healthy Volunteers: f
View:
• Patients with a suspicion (elevated PSA and/or abnormal digital rectal exam)/ diagnosis of prostate cancer
⁃ 1a. Patients who have undergone standard TRUS biopsy or TRUS with targeted biopsy (i.e cognitive TRUS, MR-TRUS fusion or TRUS + in-gantry biopsy)
Time Frame
Start Date: 2017-08-01
Completion Date: 2023-06-20
Treatments
Experimental: MRI guided biopsy + TRUS biopsy
Patients will undergo an MRI guided biopsy and standard trans-rectal ultrasonography-guided (TRUS) biopsy. Results will be compared to see which can more accurately diagnose and manage prostate cancer
Authors
Sree Tirumani, Vikas Gulani
Related Therapeutic Areas
Sponsors
Leads: Case Comprehensive Cancer Center